Cybin Inc. (NYSE AMERICAN: CYBN) Stock Information | RedChip

Cybin Inc. (NYSE AMERICAN: CYBN) Listen to this Section

$0.26
-0.0046 ( -1.74% ) 9.0M

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Market Data

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
6-k Quarterly Reports 3 Jan 23, 2024
6-k Quarterly Reports 3 Jan 08, 2024
6-k Quarterly Reports 3 Jan 04, 2024
6-k Quarterly Reports 3 Dec 06, 2023
6-k Quarterly Reports 3 Dec 05, 2023
6-k Quarterly Reports 4 Nov 30, 2023
6-k Quarterly Reports 3 Nov 21, 2023
6-k Quarterly Reports 3 Nov 21, 2023
6-k Quarterly Reports 3 Nov 16, 2023
6-k Quarterly Reports 3 Nov 15, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected